Reagena is a Finnish diagnostics growth company with product development and manufacturing facility in Kuopio region. Reagena’s mission is to be partner of choice in providing solutions and services that optimize patient care pathways while reducing the burden on healthcare.
Reagena product portfolio includes:
ReaScan®+ product family
The rapid tests based on the ReaScan+ technology enable very high levels of sensitivity and specificity. The test is read by the ReaScan+ reader. Reportable and reliable results are available in 20 minutes. ReaScan+ tests are available for the detection of acute Hantavirus and TBE virus infections as well as chemokine CXCL13.
Reagena POC® PUUMALA IgM is the easiest and fastest solution for the detection of acute Puumala virus infection. The visual test is very easy to use and extremely fast still offering very good performances in terms of sensitivity and specificity. Reagena POC tests can be used on serum, plasma or fingertip blood.
Reagena EIA tests are enzyme immunoassays for the detection of IgM and IgG antibodies against Puumala and Dobrava/Hantaan virus in human serum. With very high specificity and sensitivity, it is the ideal solution for routine centralised and reference laboratory testing. Products:
Reagena manufactures numerous Ph.Eur compliant solutions for use in quality control, production and identification. These products include buffers, stabilizers, identification reagents, controls, calibrators, standards, and indicators. You may find the pharmacopoeia compliant product of your choice from Reagena product catalogue or you may use our custom manufacturing resources for special requirements. All Reagena products are manufactured in Finland according to EN ISO 9001:2015 and EN ISO 1385:2016.